Clinical Trial Update: Effect of Pyridoxine on Behavioral Adverse Events of Levetiracetam [Phase 4]

View source ↗

Summary

Phase 4 trial updates the effect of pyridoxine on behavioral adverse events associated with levetiracetam in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)
• Pyridoxine (Pyridoxine)

Snippet

Sponsor: Nasim Tabrizi | Conditions: Epilepsy, Pyridoxine | Phase 4 | Status: COMPLETED